Icon's third quarter profit rises 22%
Clinical trials group Icon has reported third quarter profit of $61.5 million
Clinical trials group Icon has reported third quarter profit of $61.5 million (€55.7 million), an increase of 22 per cent on the same period last year.
Revenue grew by 1.8 per cent to $394.7 million, slightly below forecasts for turnover of $399.4 million, but up 7.5 per cent on a constant currency basis.
The company said it achieved net new business wins of $475 million in the period.
Icon said it had net ...